Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Murthy, J. Scanlan, R. Niven, S. Scott (Chester, Manchester, United Kingdom). Using induced sputum cell counts to guide management of difficult-to-treat asthmatics. Eur Respir J 2013; 42: Suppl. 57, 723

Member's Comments

No comment yet.

Related content which might interest you: Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Atomization inhalation on the NO content in the airway of patients with bronchial asthma Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016 Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Monitoring of airway resistance (Raw) in exacerbation of asthma Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Efficacy of carbamazepine in treatment of bronchial asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 The potential role of bronchial challenge testing to identify overtreatment of community managed asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Fast track sputum monitoring in severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Codeine for treatment of cough variant asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Benralizumab effect on blood basophil counts in adults with uncontrolled asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 The role of dysfunctional breathing in asthma control Source: International Congress 2015 – Any news from the asthma field? Year: 2015 A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015